Elsa R. Campoa

Faro, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study.

EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study.

Journal: Breast cancer research and treatment

Published: February 28, 2026

Geriatric screening and comprehensive geriatric assessment during initial oncology appointments.

Geriatric screening and comprehensive geriatric assessment during initial oncology appointments.

Journal: BMJ supportive & palliative care

Published: February 06, 2024

Exploring the feasibility and implications of cranioencephalic computed tomography in HER2-positive breast cancer: A pilot study.

Exploring the feasibility and implications of cranioencephalic computed tomography in HER2-positive breast cancer: A pilot study.

Journal: Heliyon

Published: February 01, 2024

Factors That Influence the Prescription of Antibiotic Therapy at the End-of-Life: Construction and Validation of a Scale.

Factors That Influence the Prescription of Antibiotic Therapy at the End-of-Life: Construction and Validation of a Scale.

Journal: Cureus

Published: November 19, 2022

End-of-Life Antibiotherapy: Factors Associated With Prescription.

End-of-Life Antibiotherapy: Factors Associated With Prescription.

Journal: Cureus

Published: November 18, 2022

Value of rebiopsy in advanced Epidermal Growth Factor Receptor mutated Non-Small Cell Lung Cancer: Real-world data.

Value of rebiopsy in advanced Epidermal Growth Factor Receptor mutated Non-Small Cell Lung Cancer: Real-world data.

Journal: Pulmonology

Published: April 13, 2020

Autonomy and dyspnea in palliative care: A case report.

Autonomy and dyspnea in palliative care: A case report.

Journal: Pulmonology

Published: February 27, 2019

Health-Related Quality of Life in Patients With α1 Antitrypsin Deficency: A Cross Sectional Study.

Health-Related Quality of Life in Patients With α1 Antitrypsin Deficency: A Cross Sectional Study.

Journal: Archivos de bronconeumologia

Published: March 14, 2016

Showing 1-8 of 8

Last Updated: 09/26/2026